Skip to product information
1 of 2

Lipo Lab South Africa

TB500 - OXYGENS LAB

TB500 - OXYGENS LAB

Regular price R 450.00
Regular price R 550.00 Sale price R 450.00
Sale Sold out

TB500 from OXYGENS LAB is a synthetic peptide supplied as a lyophilised powder (5 mg per vial). It is used by researchers, trainers and equine professionals who work with peptide protocols and reconstitution procedures. This page summarises what’s included, common usage patterns reported by users, safety notes and practical details — it is not medical advice, so consult a qualified practitioner before use.

At a glance

  • Form: lyophilised powder (requires reconstitution before use)
  • Concentration/size: 5 mg per vial
  • Typical users: laboratory researchers, veterinary and equine professionals
  • Texture / fragrance: dry powder (no added fragrance)
  • Cruelty-free: product composition does not include animal-derived excipients (see packaging for details)

What it is

Name Size Notes
TB500 (Thymosin Beta 4 synthetic) 5 mg vial Synthetic peptide supplied as a dry powder
Dornase alfa (where included) As stated on packaging May be combined in some formulations; check product label

How to use

  • Commonly reported protocol (examples from user communities): a loading phase of 4–8 mg per week divided into smaller doses, followed by a less frequent maintenance phase. Typical maintenance schedules reported range from 2–6 mg every two weeks. These are examples and not personalised medical advice.
  • Administration and reconstitution should be performed by a trained professional following aseptic technique; follow the manufacturer’s leaflet for exact reconstitution volumes and storage instructions after mixing.
  • Always consult a medical or veterinary professional for dosing specific to your needs and jurisdiction.

Why it works

  • Thymosin Beta 4 (TB4) — a peptide sequence studied for roles in cell migration and tissue-level repair processes in laboratory settings.
  • Dornase alfa — where present, is used in other contexts to influence mucociliary properties; inclusion varies by formulation.
  • Research contexts often explore how these molecules interact with cellular pathways; their effects depend on dose, administration and context.

What to expect

  • Reports from users vary; some note changes within a few weeks, while others require longer observation. Individual responses differ according to dose, frequency and baseline condition.
  • Do not expect uniform results; discontinue use and seek professional advice if you experience unexpected or adverse effects.

Good to know

  • This product is typically prepared for parenteral use after reconstitution — it is not a topical product.
  • Not suitable for unsupervised self-administration without appropriate training. Pregnant or breastfeeding individuals, minors and people with underlying health conditions should consult a qualified clinician before considering use.
  • Stop use and seek medical advice if you experience persistent redness, pain, allergic signs or other adverse reactions.
  • See the product leaflet or contact the supplier for regulatory and legal guidance in your area.

Ingredients (INCI)

See packaging for the full INCI and excipient list. Key components listed on the label include Thymosin Beta 4 (synthetic) and, where applicable, Dornase alfa.

Storage & care

  • Store unopened vials in a cool, dry place away from direct sunlight.
  • Follow manufacturer instructions for storage after reconstitution (if applicable).
  • Check expiry dates and discard if the vial appearance changes or the seal is broken.

Shipping & returns

Fast, tracked delivery nationwide (2–5 business days).

If you need further product information or guidance on handling, contact our customer service team for assistance.

View full details